Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms?

Research output: Contribution to journalEditorial (Academic Journal)

Original languageEnglish
Pages (from-to)134-135
Number of pages2
JournalEuropean Urology
Early online date10 Feb 2016
Publication statusPublished - Jul 2016

Structured keywords

  • Centre for Surgical Research

Cite this